Testing new treatments against harmful bacteria and fungi
Task A15: In vitro screening for antibacterial activity against public health disease pathogens
['FUNDING_OTHER'] · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · NIH-10474703
This study is testing new medicines to see if they can help fight infections caused by harmful bacteria and fungi, which could lead to better treatments for patients dealing with these infections.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF TEXAS HLTH SCIENCE CENTER (nih funded) |
| Locations | 1 site (SAN ANTONIO, UNITED STATES) |
| Trial ID | NIH-10474703 on ClinicalTrials.gov |
What this research studies
This research focuses on evaluating the effectiveness of new antibacterial and antifungal agents through laboratory testing. By using in vitro methods, the study aims to identify potential treatments that can combat infections caused by various harmful bacteria and fungi. The research also involves maintaining cultures of these pathogens and developing assays to measure the efficacy of the treatments. Patients may benefit from the discovery of new therapies that can better manage or eliminate infections.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals suffering from infections caused by antibiotic-resistant bacteria or antifungal-resistant fungi.
Not a fit: Patients with infections that are not caused by the targeted bacteria or fungi may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of more effective treatments for infections caused by resistant bacteria and fungi.
How similar studies have performed: Previous research has shown success in developing new antibacterial and antifungal agents through similar in vitro testing approaches.
Where this research is happening
SAN ANTONIO, UNITED STATES
- UNIVERSITY OF TEXAS HLTH SCIENCE CENTER — SAN ANTONIO, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: PATTERSON, THOMAS — UNIVERSITY OF TEXAS HLTH SCIENCE CENTER
- Study coordinator: PATTERSON, THOMAS
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.